Immix Biopharma Inc
IMMX6.740USD
+0.790+13.28%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
222.66M시가총액
손실P/E TTM
자세한 내용은 Immix Biopharma Inc 회사
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the application of chimeric antigen receptor cell therapy (CAR- T) in light chain (AL) Amyloidosis and select immune-mediated diseases. The Company's lead cell therapy candidate CAR-T NXC-201 (NXC-201), which is being evaluated in its ongoing United States Phase Ib/II NEXICART-2 (NCT06097832) clinical trial. Its lead program, NXC-201 is a next generation CAR-T targeting B-cell maturation antigen. CAR-T cell therapy is a type of immunotherapy that uses the patient’s own immune cells, modified with its proprietary technology. Its N-GENIUS cell engineering platform with EXPAND technology has produced clinical-stage CAR-T NXC-201, targeting B cell maturation antigen, which is autologous CAR-T being developed to treat AL Amyloidosis.
Immix Biopharma Inc 정보
종목 코드 IMMX
회사 이름Immix Biopharma Inc
상장일Dec 16, 2021
CEORachman (Ilya)
직원 수18
유형Ordinary Share
회계 연도 종료Dec 16
주소11400 West Olympic Blvd.
도시LOS ANGELES
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호90064
전화18889581084
웹사이트https://immixbio.com/
종목 코드 IMMX
상장일Dec 16, 2021
CEORachman (Ilya)
Immix Biopharma Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Jason Hsu, Ph.D.
Mr. Jason Hsu, Ph.D.
Independent Director
Independent Director
4.86M
--
Dr. Nancy T. Chang, Ph.D.
Dr. Nancy T. Chang, Ph.D.
Director
Director
421.94K
+421940.00%
Ms. Helen C. Adams, CPA
Ms. Helen C. Adams, CPA
Lead Independent Director
Lead Independent Director
174.75K
-227.00%
Dr. Magda Marquet, Ph.D.
Dr. Magda Marquet, Ph.D.
Independent Director
Independent Director
173.19K
+107035.00%
Ms. Jane M. Buchan, Ph.D.
Ms. Jane M. Buchan, Ph.D.
Independent Director
Independent Director
--
--
Mr. Carey Ng, Ph.D.
Mr. Carey Ng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Gabriel Morris
Mr. Gabriel Morris
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Ilya Rachman, M.D., Ph.D.
Dr. Ilya Rachman, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Graham Ross
Dr. Graham Ross
Acting Chief Medical Officer, Head - Clinical Development
Acting Chief Medical Officer, Head - Clinical Development
--
--
Dr. Vladimir Torchilin, Ph.D.
Dr. Vladimir Torchilin, Ph.D.
Scientific Co-Founder
Scientific Co-Founder
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Jason Hsu, Ph.D.
Mr. Jason Hsu, Ph.D.
Independent Director
Independent Director
4.86M
--
Dr. Nancy T. Chang, Ph.D.
Dr. Nancy T. Chang, Ph.D.
Director
Director
421.94K
+421940.00%
Ms. Helen C. Adams, CPA
Ms. Helen C. Adams, CPA
Lead Independent Director
Lead Independent Director
174.75K
-227.00%
Dr. Magda Marquet, Ph.D.
Dr. Magda Marquet, Ph.D.
Independent Director
Independent Director
173.19K
+107035.00%
Ms. Jane M. Buchan, Ph.D.
Ms. Jane M. Buchan, Ph.D.
Independent Director
Independent Director
--
--
Mr. Carey Ng, Ph.D.
Mr. Carey Ng, Ph.D.
Independent Director
Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Fri, Feb 6
마지막 업데이트: Fri, Feb 6
주주
주주 유형
주주
주주
비율
Hsu (Jason)
9.32%
GKCC, LLC
6.21%
Rachman (Ilya M)
2.19%
The Vanguard Group, Inc.
2.10%
Ng (Carey)
2.00%
기타
78.17%
주주
주주
비율
Hsu (Jason)
9.32%
GKCC, LLC
6.21%
Rachman (Ilya M)
2.19%
The Vanguard Group, Inc.
2.10%
Ng (Carey)
2.00%
기타
78.17%
주주 유형
주주
비율
Individual Investor
16.64%
Corporation
6.21%
Investment Advisor
5.13%
Investment Advisor/Hedge Fund
1.00%
Hedge Fund
0.21%
Venture Capital
0.07%
Research Firm
0.05%
기타
70.69%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
69
3.66M
7.01%
-955.81K
2025Q3
60
2.79M
8.55%
-1.92M
2025Q2
65
14.67M
52.67%
-1.12M
2025Q1
66
14.50M
53.34%
-1.02M
2024Q4
67
14.42M
52.43%
-1.29M
2024Q3
66
15.60M
56.77%
-243.92K
2024Q2
66
15.89M
59.32%
-308.72K
2024Q1
64
15.43M
77.52%
+5.90M
2023Q4
57
11.10M
62.12%
+3.00M
2023Q3
52
12.47M
73.23%
+2.63M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Hsu (Jason)
4.86M
9.32%
--
--
Apr 22, 2025
GKCC, LLC
3.24M
6.21%
--
--
Apr 22, 2025
Rachman (Ilya M)
1.14M
2.19%
+746.00
+0.07%
Dec 10, 2025
The Vanguard Group, Inc.
730.16K
1.4%
+31.63K
+4.53%
Sep 30, 2025
Ng (Carey)
1.05M
2%
--
--
Apr 22, 2025
Bleichroeder LP
850.00K
1.63%
--
--
Sep 30, 2025
Chang (Nancy T)
421.94K
1.29%
+421.94K
--
Sep 08, 2025
Morris (Gabriel S)
586.41K
1.12%
+770.00
+0.13%
Dec 10, 2025
Geode Capital Management, L.L.C.
187.48K
0.36%
+26.36K
+16.36%
Sep 30, 2025
Adams (Helen C)
174.75K
0.34%
-227.00
-0.13%
Apr 22, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
비율0.01%
Dimensional US Core Equity 1 ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
